See more : Bank7 Corp. (BSVN) Income Statement Analysis – Financial Results
Complete financial analysis of SYNLAB AG (SYAB.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SYNLAB AG, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Euro Asia Exports Limited (EUROASIA.BO) Income Statement Analysis – Financial Results
- Jiumaojiu International Holdings Limited (9922.HK) Income Statement Analysis – Financial Results
- Kinergy Corporation Ltd. (3302.HK) Income Statement Analysis – Financial Results
- SmartFinancial, Inc. (SMBK) Income Statement Analysis – Financial Results
- Global Petroleum Limited (GBP.L) Income Statement Analysis – Financial Results
SYNLAB AG (SYAB.DE)
About SYNLAB AG
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.64B | 3.25B | 3.76B | 2.62B | 1.91B | 1.81B | 1.82B | 1.57B | 844.71M |
| Cost of Revenue | 2.07B | 776.92M | 942.43M | 684.52M | 437.01M | 412.51M | 394.08M | 351.34M | 193.51M |
| Gross Profit | 569.89M | 2.47B | 2.82B | 1.94B | 1.47B | 1.40B | 1.42B | 1.22B | 651.20M |
| Gross Profit Ratio | 21.63% | 76.10% | 74.97% | 73.89% | 77.07% | 77.18% | 78.31% | 77.62% | 77.09% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 150.15M | 75.84M | 52.86M | 39.64M | 776.06M | 736.48M | 823.06M | 0.00 | 376.75M |
| Selling & Marketing | 30.67M | 52.34M | 53.57M | 43.14M | 40.76M | 39.23M | 46.56M | 0.00 | 23.90M |
| SG&A | 424.12M | 128.18M | 106.43M | 82.78M | 816.82M | 775.71M | 869.61M | 689.23M | 400.65M |
| Other Expenses | -28.46M | 1.89B | 1.77B | 1.40B | 17.00M | 18.00M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 452.58M | 2.02B | 1.88B | 1.49B | 1.41B | 1.28B | 1.40B | 1.15B | -680.78M |
| Cost & Expenses | 2.52B | 2.80B | 2.82B | 2.17B | 1.85B | 1.69B | 1.79B | 1.50B | -487.27M |
| Interest Income | 16.45M | 7.83M | 3.28M | 919.00K | 23.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 107.72M | 61.94M | 128.16M | 178.40M | 188.00M | 139.37M | 171.89M | 274.59M | 124.40M |
| Depreciation & Amortization | 363.57M | 514.30M | 265.36M | 341.22M | 90.23M | 88.66M | 124.31M | 104.40M | -48.97M |
| EBITDA | 411.43M | 967.00M | 1.20B | 778.62M | 264.06M | 260.33M | 295.30M | 280.20M | 134.99M |
| EBITDA Ratio | 15.61% | 29.75% | 31.80% | 29.70% | 13.85% | 14.40% | 16.26% | 17.85% | 15.98% |
| Operating Income | 117.31M | 452.70M | 914.53M | 437.40M | 173.83M | 171.67M | 171.00M | 175.79M | 86.03M |
| Operating Income Ratio | 4.45% | 13.93% | 24.29% | 16.69% | 9.12% | 9.50% | 9.41% | 11.20% | 10.18% |
| Total Other Income/Expenses | 25.70M | -169.72M | -108.89M | -312.14M | -166.49M | -191.18M | -192.21M | -276.91M | -130.18M |
| Income Before Tax | 143.04M | 282.98M | 805.64M | 125.26M | -94.62M | -19.52M | -144.90M | -202.75M | -153.98M |
| Income Before Tax Ratio | 5.43% | 8.71% | 21.40% | 4.78% | -4.96% | -1.08% | -7.98% | -12.91% | -18.23% |
| Income Tax Expense | 50.06M | 130.46M | 195.32M | 87.32M | 25.01M | 30.60M | 19.01M | 24.91M | 14.52M |
| Net Income | 92.27M | 150.70M | 624.76M | 37.94M | -121.87M | -51.27M | -165.57M | -230.40M | -168.88M |
| Net Income Ratio | 3.50% | 4.64% | 16.59% | 1.45% | -6.39% | -2.84% | -9.11% | -14.67% | -19.99% |
| EPS | 0.42 | 0.68 | 2.84 | 0.17 | -0.09 | -0.04 | -0.12 | -0.19 | -0.14 |
| EPS Diluted | 0.42 | 0.68 | 2.84 | 0.17 | -0.09 | -0.04 | -0.12 | -0.19 | -0.14 |
| Weighted Avg Shares Out | 219.72M | 221.56M | 215.16M | 222.22M | 1.35B | 1.35B | 1.35B | 1.18B | 1.18B |
| Weighted Avg Shares Out (Dil) | 220.96M | 221.87M | 215.22M | 222.22M | 1.35B | 1.35B | 1.35B | 1.18B | 1.18B |
Source: https://incomestatements.info
Category: Stock Reports